Literature DB >> 22341517

The role of mRNA translation in direct MHC class I antigen presentation.

Sébastien Apcher1, Bénédicte Manoury, Robin Fåhraeus.   

Abstract

It has been over 40 years since it was discovered that the major histocompatibility (MHC) class I molecules present peptides for the CD8 T cell-mediated immune response. The pathways for delivering and processing peptides for the MHC class I complexes have since been thoroughly studied but it is only until more recently that we start to understand the mechanisms that provide peptide material for the endogenous MHC class I pathway. Interestingly, the main source of antigenic peptide substrates does not come from the same mRNA translation mechanism that produces full length proteins but from ribosomes which products sole purpose might be to produce antigenic peptide substrates. We will discuss the latest development in this field and its implications for a better understanding of one of the corner stones for how the immune system distinguishes between self and non-self. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341517     DOI: 10.1016/j.coi.2012.01.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  11 in total

1.  Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides.

Authors:  Diego J Farfán-Arribas; Lawrence J Stern; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

2.  Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.

Authors:  Giora I Morozov; Huaying Zhao; Michael G Mage; Lisa F Boyd; Jiansheng Jiang; Michael A Dolan; Ramesh Venna; Michael A Norcross; Curtis P McMurtrey; William Hildebrand; Peter Schuck; Kannan Natarajan; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

Review 3.  Pathways of antigen processing.

Authors:  Janice S Blum; Pamela A Wearsch; Peter Cresswell
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo.

Authors:  Daphné Benteyn; Sébastien Anguille; Sandra Van Lint; Carlo Heirman; An Mt Van Nuffel; Jurgen Corthals; Sebastian Ochsenreither; Wim Waelput; Katrien Van Beneden; Karine Breckpot; Viggo Van Tendeloo; Kris Thielemans; Aude Bonehill
Journal:  Mol Ther Nucleic Acids       Date:  2013-11-19       Impact factor: 10.183

5.  Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames.

Authors:  Céline M Laumont; Tariq Daouda; Jean-Philippe Laverdure; Éric Bonneil; Olivier Caron-Lizotte; Marie-Pierre Hardy; Diana P Granados; Chantal Durette; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Nat Commun       Date:  2016-01-05       Impact factor: 14.919

Review 6.  Impacts of Low Temperature on the Teleost Immune System.

Authors:  Quinn H Abram; Brian Dixon; Barbara A Katzenback
Journal:  Biology (Basel)       Date:  2017-11-22

7.  Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action.

Authors:  James B Gilmore; Anthony D Kelleher; David A Cooper; John M Murray
Journal:  PLoS Comput Biol       Date:  2013-03-28       Impact factor: 4.475

8.  A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.

Authors:  Cécile Voisset; Chrysoula Daskalogianni; Marie-Astrid Contesse; Anne Mazars; Hratch Arbach; Marie Le Cann; Flavie Soubigou; Sébastien Apcher; Robin Fåhraeus; Marc Blondel
Journal:  Dis Model Mech       Date:  2014-02-20       Impact factor: 5.758

9.  mRNAs containing NMD-competent premature termination codons are stabilized and translated under UPF1 depletion.

Authors:  Won Kyu Kim; SeongJu Yun; Yujin Kwon; Kwon Tae You; Nara Shin; Jiyoon Kim; Hoguen Kim
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

10.  Most human proteins made in both nucleus and cytoplasm turn over within minutes.

Authors:  Sabyasachi Baboo; Bhaskar Bhushan; Haibo Jiang; Chris R M Grovenor; Philippe Pierre; Benjamin G Davis; Peter R Cook
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.